Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Neuropathy peripheral
ADR ID BADD_A03063
ADR Hierarchy
17      Nervous system disorders
17.09      Peripheral neuropathies
17.09.03      Peripheral neuropathies NEC
17.09.03.003      Neuropathy peripheral
Description A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA. | Inflammation of multiple nerves. [MeSH]
MedDRA Code 10029331
MeSH ID D009443; D010523
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hereditary and idiopathic peripheral neuropathy | Hereditary and idiopathic peripheral neuropathy, other | Inflammatory and toxic neuropathy | Neuritis peripheral | Neuropathy | Neuropathy - (NOS) | Neuropathy NOS | Neuropathy peripheral | Other hereditary and idiopathic peripheral neuropathy | Other inflammatory and toxic neuropathies | Other specified idiopathic peripheral neuropathy | Peripheral neuritis | Peripheral neuritis antepartum | Peripheral neuritis in pregnancy | Peripheral neuritis in pregnancy, unspecified as to episode of care | Peripheral neuritis in pregnancy, with delivery | Peripheral neuritis in pregnancy, with delivery, with mention of postpartum complication | Peripheral neuritis NOS | Peripheral neuritis postartum | Peripheral neuropathy aggravated | Peripheral neuropathy NOS | Unspecified hereditary and idiopathic peripheral neuropathy | Unspecified idiopathic peripheral neuropathy | Unspecified inflammatory and toxic neuropathies | Peripheral nerve disorder NOS | Peripheral neuritis postpartum | Cold sensitivity neuropathy | Chemotherapy induced peripheral neuropathy | Peripheral neuropathy | Neuritis | Neuritides | Neuritis, Peripheral | Neuritides, Peripheral | Peripheral Neuritides | Peripheral Neuritis | Neuritis, Sensory | Neuritides, Sensory | Sensory Neuritides | Sensory Neuritis | Polyneuritis | Polyneuritides | Neuritis, Motor | Motor Neuritides | Motor Neuritis | Neuritides, Motor
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01567Nilotinib--
BADD_D01572Nitisinone0.004312%
BADD_D01576Nitrofurantoin--
BADD_D01577Nitrofurantoin (macrocrystals)--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01580Nitrous oxide0.001161%
BADD_D01581Nivolumab--
BADD_D01587Norfloxacin--
BADD_D01588Nortriptyline--
BADD_D01589Nortriptyline hydrochloride--
BADD_D01590Nuvaring--
BADD_D01595Octreotide acetate--
BADD_D01598Ofloxacin0.000083%
BADD_D01599Olanzapine--
BADD_D01601Olaparib--
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01616Onabotulinumtoxina--
BADD_D01624Orlistat--
BADD_D01633Oxaliplatin0.012659%
BADD_D01653Paclitaxel0.011674%
BADD_D01654Palbociclib0.032213%
BADD_D01668Pantoprazole--
BADD_D01679Paroxetine--
BADD_D01680Paroxetine hydrochloride--
BADD_D01681Paroxetine hydrochloride hemihydrate--
BADD_D01682Paroxetine impurity a--
BADD_D01683Paroxetine mesylate--
BADD_D01696Peginterferon alfa-2b--
BADD_D01701Pemetrexed0.000168%
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 17 Pages
ADReCS-Target
ADR Term Drug Name Target